5-150848520-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000522154.2(IRGM):āc.397A>Gā(p.Thr133Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000129 in 1,551,684 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars).
Frequency
Consequence
ENST00000522154.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IRGM | NM_001145805.2 | c.397A>G | p.Thr133Ala | missense_variant | 2/2 | ENST00000522154.2 | NP_001139277.1 | |
IRGM | NM_001346557.2 | c.397A>G | p.Thr133Ala | missense_variant | 2/4 | NP_001333486.1 | ||
IRGM | NR_170598.1 | n.1512A>G | non_coding_transcript_exon_variant | 2/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IRGM | ENST00000522154.2 | c.397A>G | p.Thr133Ala | missense_variant | 2/2 | 1 | NM_001145805.2 | ENSP00000428220 | P1 | |
IRGM | ENST00000520549.1 | c.25A>G | p.Thr9Ala | missense_variant, NMD_transcript_variant | 1/4 | 1 | ENSP00000429819 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152146Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000648 AC: 1AN: 154250Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 81844
GnomAD4 exome AF: 7.15e-7 AC: 1AN: 1399538Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 690286
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152146Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74324
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The IRGM p.Thr133Ala variant was not identified in the literature nor was it identified in ClinVar, Cosmic or LOVD 3.0. The variant was identified in dbSNP (ID: rs1020311575) and was also identified in control databases in 1 of 154250 chromosomes at a frequency of 0.000006 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following population: European (non-Finnish) in 1 of 59698 chromosomes (freq: 0.000017), but not in the African, Latino, Ashkenazi Jewish, East Asian, European (Finnish), Other, and South Asian populations. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. The p.Thr133 residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at